Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Zinman

Showing results (81-90 of 391) with videos related to

Pageof 40
Sort By:
Breast Cancer Research and Treatment|March 17, 2006
Diabetes mellitus and breast cancer: a retrospective population-based cohort studyLorraine L Lipscombe, Pamela J Goodwin, Bernard Zinman, et al.
Pediatric Nephrology (Berlin, Germany)|March 31, 2007
Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youthRavi Retnakaran, Philip W Connelly, Stewart B Harris, et al.
Pediatric Research|June 6, 2013
Vitamin D status and cardiometabolic assessment in infancySimone Kew, Jill K Hamilton, Chang Ye, et al.
Molecular Metabolism|December 4, 2018
Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetesYury O Nunez Lopez, Ravi Retnakaran, Bernard Zinman, et al.
Canadian Journal of Diabetes|October 18, 2015
Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc AnalysisBernard Zinman, Bo Ahrén, Dietmar Neubacher, et al.
Clinical Endocrinology|June 17, 2010
Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartumRavi Retnakaran, Ying Qi, Philip W Connelly, et al.
Cardiovascular Diabetology|October 11, 2018
Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetesSadia Mehmood, Chang Ye, Philip W Connelly, et al.
The Journal of Pediatrics|February 24, 2006
Nontraditional cardiovascular risk factors in pediatric metabolic syndromeRavi Retnakaran, Bernard Zinman, Philip W Connelly, et al.
Diabetes & Vascular Disease Research|June 7, 2018
Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancyHarpreet S Bajaj, Chang Ye, Anthony J Hanley, et al.
Advances in Therapy|March 26, 2015
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trialLinong Ji, Bernard Zinman, Sanjay Patel, et al.
Pageof 40

Showing results (81-90 of 391) with videos related to

Sort By:
Pageof 40
Breast Cancer Research and Treatment|March 17, 2006
Diabetes mellitus and breast cancer: a retrospective population-based cohort studyLorraine L Lipscombe, Pamela J Goodwin, Bernard Zinman, et al.
Pediatric Nephrology (Berlin, Germany)|March 31, 2007
Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youthRavi Retnakaran, Philip W Connelly, Stewart B Harris, et al.
Pediatric Research|June 6, 2013
Vitamin D status and cardiometabolic assessment in infancySimone Kew, Jill K Hamilton, Chang Ye, et al.
Molecular Metabolism|December 4, 2018
Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetesYury O Nunez Lopez, Ravi Retnakaran, Bernard Zinman, et al.
Canadian Journal of Diabetes|October 18, 2015
Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc AnalysisBernard Zinman, Bo Ahrén, Dietmar Neubacher, et al.
Clinical Endocrinology|June 17, 2010
Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartumRavi Retnakaran, Ying Qi, Philip W Connelly, et al.
Cardiovascular Diabetology|October 11, 2018
Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetesSadia Mehmood, Chang Ye, Philip W Connelly, et al.
The Journal of Pediatrics|February 24, 2006
Nontraditional cardiovascular risk factors in pediatric metabolic syndromeRavi Retnakaran, Bernard Zinman, Philip W Connelly, et al.
Diabetes & Vascular Disease Research|June 7, 2018
Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancyHarpreet S Bajaj, Chang Ye, Anthony J Hanley, et al.
Advances in Therapy|March 26, 2015
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trialLinong Ji, Bernard Zinman, Sanjay Patel, et al.
Pageof 40